Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity
Abstract Excessive glucocorticoid (GC) action is linked to various metabolic disorders. Recent findings suggest that disrupting skeletal GC signaling prevents bone loss and alleviates metabolic disorders in high-fat diet (HFD)-fed obese mice, underpinning the neglected contribution of skeletal GC ac...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Portfolio
2024-10-01
|
| סדרה: | Nature Communications |
| גישה מקוונת: | https://doi.org/10.1038/s41467-024-52965-4 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
